Brennan IP Services - Writing Samples

Patents

“Antibodies to Matrix Metalloproteinase 9.” U.S. Patent No. 8,377,443 (Feb. 19, 2103) [Link]
“Antibodies to Matrix Metalloproteinase 9.” U.S. Patent No. 8,501,916 (Aug. 6, 2103) [Link]
“Catalytic Domains from Lysyl Oxidase and LOXL2.” U.S. Patent No. 8,512,990 (Aug. 20, 2013) [Links]
“Antibodies that Bind Lysyl Oxidase-Like 2 (LOXL2).” U.S. Patent No. 8,680,246 March 25, 2014) [Link]
“Methods and Compositions for Modulating Peripheral Immune Function.” U.S. Patent No. 8,785,190 (July 22, 2014) [Links]
“Methods and Compositions for treating Neural Degeneration.” U.S. Patent No. 8,945,919 (Feb. 3, 2015) [Link]

Patent Applications

“Methods and Compositions for Production of Acetaldehyde.” U.S. Patent Application Publication No. 2009/0246841 (Oct. 1, 2009) [Link]
“Methods and Compositions for Treatment of Neovascularization.” U.S. Patent Application Publication No. 2010/0203062 (Aug. 12, 2010) [Link]
“Chemotherapeutic Methods and Compositions.” U.S. Patent Application Publication No. 2010/0209415 (Aug. 19, 2010) [Link]
“Extracellular Matrix from Pluripotent Cells.” U.S. Patent Application Publication No. 2010/0310529 (Dec. 9, 2010) [Link]
“In vivo Screening Assays.” U.S. Patent Application Publication No. 2011/0044907 (Feb. 24, 2011) [Link]
“Methods and Compositions for Treatment of Pulmonary Fibrotic Disorders.” U.S. Patent Application Publication No. 2011/0044981 (Feb. 24, 2011) [Link]
“Therapeutic Methods and Compositions (for modulating fibroblast activation in tumors).” U.S. Patent Application Publication No. 2011/0076272 (March 31, 2011) [Link]
“Methods and Compositions for Treatment of Ocular Fibrosis.” U.S. Patent Application Publication No. 2011/0076285 (March 31, 2011) [Link]
“Neural Regenerating Cells with Alterations in DNA Methylation.” U.S. Patent Application Publication No. 2011/0136114 (June 9, 2011) [Link]
“In vitro Screening Assays.” U.S. Patent Application Publication No. 2011/0207144 (Aug. 25, 2011) [Link]
“Methods and Compositions for Modulating Angiogenesis and Vasculogenesis.” U.S. Patent Application Publication No. 2013/0195817 (Aug. 1, 2013)[Link]
“Neurogenic and Gliogenic Factors and Assays Therefor.” U.S. Patent Application Publication No. 2013/0210000 (Aug. 15, 2013) [Link]
“Methods and Compositions for Treatment of Retinal Degeneration.” U.S. Patent Application Publication No. 2014/0099291 (Apr. 10, 2014) [Link]
“Methods and Compositions for Treatment of Traumatic Brain Injury and for Modulation of Migration of Neurogenic Cells.” U.S. Patent Application Publication No. 2014/0186316 (Jul. 3, 2014) [Link]
“Methods and Compositions for Normalization of Tumor Vasculature by Inhibition of LOXL2.” U.S. Patent Application Publication No. 2014/0186340 (July 3, 2014) [Link]

Brennan IP Services - Prosecution Samples

“Differentiation of Bone Marrow Stromal Cells to Neural Cells or Skeletal Muscle Cells by Introduction of Notch Gene.” U.S. Patent No. 7,682,825 (March 23, 2010) [Link]
“Use of Materials for Treatment of Central Nervous System Lesions.” U.S. Patent No. 8,092,792 (Jan. 10, 2012) [Link]
“Bone Marrow Stromal Cells Comprising a Nucleic Acid Encoding a Notch Intracellular Domain.” U.S. Patent No. 8,133,725 (March 13, 2012) [Link]
“Method of Inducing Differentiation of Bone Marrow Stromal Cells to Neural Precursor Cells, Neural Precursor Cells, and Uses Thereof.” U.S. Patent No. 8,361,456 (Jan. 29, 2013) [Link]
“Neural Precursor Cells Produced from Bone Marrow Stromal Cells Containing an Exogenous Nucleic Acid Encoding a Notch Intracellular Domain (NICD)” US Patent No. 8,969,078 (March 3, 2015) [Link]